StandardStandard

Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans. / Hoiland, Ryan L; Tremblay, Joshua C; Stacey, Benjamin S et al.
Yn: Journal of Physiology, Cyfrol 598, Rhif 19, 10.2020, t. 4225-4236.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Hoiland, RL, Tremblay, JC, Stacey, BS, Coombs, GB, Nowak-Flück, D, Tymko, MM, Patrician, A, Stembridge, M, Howe, CA, Bailey, DM, Green, DJ, MacLeod, DB & Ainslie, PN 2020, 'Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans', Journal of Physiology, cyfrol. 598, rhif 19, tt. 4225-4236. https://doi.org/10.1113/JP280141

APA

Hoiland, R. L., Tremblay, J. C., Stacey, B. S., Coombs, G. B., Nowak-Flück, D., Tymko, M. M., Patrician, A., Stembridge, M., Howe, C. A., Bailey, D. M., Green, D. J., MacLeod, D. B., & Ainslie, P. N. (2020). Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans. Journal of Physiology, 598(19), 4225-4236. https://doi.org/10.1113/JP280141

CBE

Hoiland RL, Tremblay JC, Stacey BS, Coombs GB, Nowak-Flück D, Tymko MM, Patrician A, Stembridge M, Howe CA, Bailey DM, et al. 2020. Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans. Journal of Physiology. 598(19):4225-4236. https://doi.org/10.1113/JP280141

MLA

VancouverVancouver

Hoiland RL, Tremblay JC, Stacey BS, Coombs GB, Nowak-Flück D, Tymko MM et al. Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans. Journal of Physiology. 2020 Hyd;598(19):4225-4236. doi: 10.1113/JP280141

Author

Hoiland, Ryan L ; Tremblay, Joshua C ; Stacey, Benjamin S et al. / Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans. Yn: Journal of Physiology. 2020 ; Cyfrol 598, Rhif 19. tt. 4225-4236.

RIS

TY - JOUR

T1 - Acute reductions in haematocrit increase flow-mediated dilatation independent of resting nitric oxide bioavailability in humans

AU - Hoiland, Ryan L

AU - Tremblay, Joshua C

AU - Stacey, Benjamin S

AU - Coombs, Geoff B

AU - Nowak-Flück, Daniela

AU - Tymko, Michael M

AU - Patrician, Alexander

AU - Stembridge, Mike

AU - Howe, Connor A

AU - Bailey, Damian M

AU - Green, Daniel J

AU - MacLeod, David B

AU - Ainslie, Philip N

N1 - © 2020 The Authors. The Journal of Physiology © 2020 The Physiological Society.

PY - 2020/10

Y1 - 2020/10

N2 - Changes in haematocrit influence nitric oxide signalling through alterations in shear stress stimuli and haemoglobin scavenging of nitric oxide; these two regulatory factors have not been assessed simultaneously Isovolumic haemodilution led to a marked increase in brachial artery flow-mediated dilatation in humans The increase in flow-mediated dilatation occurred in the face of an unaltered shear stress stimulus for vasodilatation and reduced resting steady-state nitric oxide levels in the blood Collectively, our data point towards haemoglobin scavenging of nitric oxide as a key regulatory factor of brachial flow-mediated dilatation and highlight the importance of the simultaneous consideration of nitric oxide production and inactivation when investigating vascular function in humans ABSTRACT: Haemoglobin (Hb) may impact the transduction of endothelium-dependent and nitric oxide (NO)-mediated vasodilator activity, given its contribution to shear stress stimuli and diverse biochemical reactions with NO. We hypothesized that an acute reduction in [Hb] and haematocrit (Hct) would increase brachial artery flow-mediated dilatation (FMD). In 11 healthy males (28 ± 7 years; 23 ± 2 kg m-2 ), FMD (Duplex ultrasound), arterial blood gases, Hct and [Hb], blood viscosity, and NO metabolites (ozone-based chemiluminescence) were measured before and after isovolumic haemodilution, where ∼20% of whole blood was removed and replaced with 5% human serum albumin. Haemodilution reduced Hct by 18 ± 2% (P < 0.001) and whole blood viscosity by 22 ± 5% (P < 0.001). Plasma nitrite (P = 0.01), S-nitrosothiols (P = 0.03) and total red blood cell NO (P = 0.001) were collectively reduced by ∼15-40%. Brachial artery FMD increased by ∼160% from 3.8 ± 2.1 to 9.7 ± 4.5% (P = 0.004). Statistical covariation for the shear stress stimulus did not alter FMD, indicating that the increase in FMD was not directly related to alterations in whole blood viscosity and the shear stimulus. Collectively, these findings indicate that haemoglobin scavenging of NO appears to be an important factor in the regulation of FMD under normal conditions through constraint of endothelium-dependent NO-mediated vasodilatation in healthy humans.

AB - Changes in haematocrit influence nitric oxide signalling through alterations in shear stress stimuli and haemoglobin scavenging of nitric oxide; these two regulatory factors have not been assessed simultaneously Isovolumic haemodilution led to a marked increase in brachial artery flow-mediated dilatation in humans The increase in flow-mediated dilatation occurred in the face of an unaltered shear stress stimulus for vasodilatation and reduced resting steady-state nitric oxide levels in the blood Collectively, our data point towards haemoglobin scavenging of nitric oxide as a key regulatory factor of brachial flow-mediated dilatation and highlight the importance of the simultaneous consideration of nitric oxide production and inactivation when investigating vascular function in humans ABSTRACT: Haemoglobin (Hb) may impact the transduction of endothelium-dependent and nitric oxide (NO)-mediated vasodilator activity, given its contribution to shear stress stimuli and diverse biochemical reactions with NO. We hypothesized that an acute reduction in [Hb] and haematocrit (Hct) would increase brachial artery flow-mediated dilatation (FMD). In 11 healthy males (28 ± 7 years; 23 ± 2 kg m-2 ), FMD (Duplex ultrasound), arterial blood gases, Hct and [Hb], blood viscosity, and NO metabolites (ozone-based chemiluminescence) were measured before and after isovolumic haemodilution, where ∼20% of whole blood was removed and replaced with 5% human serum albumin. Haemodilution reduced Hct by 18 ± 2% (P < 0.001) and whole blood viscosity by 22 ± 5% (P < 0.001). Plasma nitrite (P = 0.01), S-nitrosothiols (P = 0.03) and total red blood cell NO (P = 0.001) were collectively reduced by ∼15-40%. Brachial artery FMD increased by ∼160% from 3.8 ± 2.1 to 9.7 ± 4.5% (P = 0.004). Statistical covariation for the shear stress stimulus did not alter FMD, indicating that the increase in FMD was not directly related to alterations in whole blood viscosity and the shear stimulus. Collectively, these findings indicate that haemoglobin scavenging of NO appears to be an important factor in the regulation of FMD under normal conditions through constraint of endothelium-dependent NO-mediated vasodilatation in healthy humans.

KW - Biological Availability

KW - Brachial Artery/diagnostic imaging

KW - Dilatation

KW - Endothelium, Vascular

KW - Hematocrit

KW - Humans

KW - Male

KW - Nitric Oxide

KW - Regional Blood Flow

KW - Vasodilation

U2 - 10.1113/JP280141

DO - 10.1113/JP280141

M3 - Article

C2 - 32639605

VL - 598

SP - 4225

EP - 4236

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 19

ER -